The Covid-19 pandemic exposed deep failures in global health governance. That much is now widely acknowledged, even by institutions that initially resisted self-examination. For example, the recent Lancet Commission on Covid-19 substituted advocacy for analysis, evaded institutional accountability, and ultimately clarified little about why global pandemic governance failed.

What remains unsettled—and largely undiscussed in public—is what those failures imply for the future of international health cooperation, and especially for the role of the World Health Organization.

The International Health Reform Project (IHRP) was convened to confront that question directly. The IHRP is an independent international group, though its work is closely linked to Brownstone through the participation of three of its Fellows who wrote this article, two of whom served as co-chairs.

Its work is unusually detailed, wide-ranging, and blunt. It does not argue that the pandemic was inevitable, nor that failure was merely the product of bad luck or limited information. Instead, it documents how institutional incentives, governance structures, and political pressures shaped decisions in ways that repeatedly undermined transparency, proportionality, and scientific rigor.

The Panel’s findings matter well beyond debates about the past. They arrive at a moment when the United States has withdrawn from the WHO, when the Organization is seeking expanded authority through amended International Health Regulations and a new pandemic agreement, and when governments around the world are quietly reassessing whether the current model of global health governance is fit for purpose.

The question now is not simply whether the WHO failed, but what should follow from that failure—especially for the United States and its allies.

I. What the IHRP Found: Failure Was Structural, Not Accidental

The IHRP report reaches a clear conclusion: the problems revealed during Covid-19 were not isolated mistakes, but the predictable outcome of institutional design choices made over decades.

Several findings are central.

First, the WHO failed in its core pandemic function. The Organization was created to detect, assess, and coordinate responses to transnational infectious disease threats. Yet during the early stages of Covid-19 it was slow to challenge incomplete or misleading information, reluctant to escalate warnings in the face of political pressure, and inconsistent in its guidance once the emergency was declared. These failures had real consequences, shaping national responses during the narrow window when early action mattered most.

Second, politicization was not an aberration but a recurring constraint. The Panel documents how deference to powerful member states, especially where transparency was most critical, distorted risk communication and delayed independent investigation. This was not simply a failure of leadership, but a consequence of governance rules that place political consensus above timely error correction.

Third, the Organization entered the pandemic already institutionally overstretched. Over time, the WHO’s mandate expanded far beyond communicable disease control into a wide array of social, behavioral, and environmental domains, often with limited connection to pandemic preparedness. The result was an organization attempting to function simultaneously as a technical agency, a development actor, a norm-setting body, and a political convenor—without the clarity or discipline required for crisis response.

Fourth, post-pandemic reforms did not address these underlying weaknesses. Instead of a rigorous institutional autopsy, the response to failure was to seek expanded authority: broader emergency powers, new compliance expectations for states, and additional permanent structures. The Panel is explicit that expanding scope without correcting governance failures risks entrenching the very dynamics that contributed to poor performance in the first place.

Taken together, the IHRP’s conclusion is stark: global health governance failed not because the task was impossible, but because the system lacked the incentives and safeguards needed to prioritize evidence, transparency, and accountability under pressure.

II. Withdrawal Was Not Reckless, but It Was Incomplete

Against this backdrop, the United States’ decision to withdraw from the WHO should not be understood as a rejection of global health cooperation. It was a response—long delayed—to an institution that failed its most important test and then sought to expand its authority without a credible reckoning.

Withdrawal restored policy autonomy and signaled that continued participation could not be taken for granted in the absence of reform. But withdrawal alone does not constitute a strategy.

The United States remains the world’s largest funder of global health efforts and the most capable actor in disease surveillance, biomedical research, and emergency response. Pandemics, by definition, do not respect borders. Leaving the WHO does not eliminate US interests in global outbreak detection, technical standards, or information sharing. It merely changes the terms on which those interests must now be pursued.

The risk is not disengagement, but strategic drift. Without a clear articulation of what comes next—what functions still matter, where cooperation is indispensable, and under what conditions institutional engagement should resume—withdrawal can harden into absence. And absence does not create neutrality; it simply cedes influence over emerging norms to others.

This is where the IHRP report becomes especially important. It provides a baseline diagnosis that future US administrations—of either party—will have to confront. Even if the current administration favors bilateral approaches, a future Democratic administration is likely to seek re-entry into the WHO. The critical question is whether that re-entry would be unconditional, or whether it would be used as leverage........

© Eurasia Review